Greta Carioli
Overview
Explore the profile of Greta Carioli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raimondi F, Centanni S, Luppi F, Aliberti S, Blasi F, Rogliani P, et al.
Monaldi Arch Chest Dis
. 2024 Oct;
94(4).
PMID: 39470221
Predictors of outcomes are essential to identifying severe COVID-19 cases and optimizing treatment and care settings. The respiratory rate-oxygenation (ROX) index, originally introduced for predicting the failure of non-invasive support...
2.
Cirelli C, Limonta R, Carioli G, DElia E, Ameri P, Inciardi R, et al.
Eur J Intern Med
. 2024 Aug;
130:71-78.
PMID: 39117554
Background: Worsening Heart Failure (WHF) is associated with adverse prognosis. Identifying novel prognostic markers in WHF is crucial. Gait speed (GS), a validated frailty index, is an easily obtainable parameter...
3.
Barbui T, Vannucchi A, De Stefano V, Carobbio A, Ghirardi A, Carioli G, et al.
NEJM Evid
. 2024 Feb;
2(6):EVIDoa2200335.
PMID: 38320126
BACKGROUND: Whether phlebotomy alone can adequately maintain target hematocrit in patients with low-risk polycythemia vera (PV) remains elusive. METHODS: In a phase 2 open-label randomized trial, we compared ropeginterferon alfa-2b...
4.
Barbui T, Carobbio A, De Stefano V, Alvarez-Larran A, Ghirardi A, Carioli G, et al.
Ann Hematol
. 2023 Dec;
103(2):437-442.
PMID: 38060001
In patients with low-risk polycythemia vera, exposure to low-dose Ropeginterferon alfa-2b (Ropeg) 100 µg every 2 weeks for 2 years was more effective than the standard treatment of therapeutic phlebotomy...
5.
Barbui T, Gavazzi A, Sciatti E, Finazzi M, Ghirardi A, Carioli G, et al.
Curr Hematol Malig Rep
. 2023 May;
18(4):105-112.
PMID: 37221411
Purpose Of Review: This review focuses on vascular complications associated with chronic myeloproliferative neoplasms (MPN) and more specifically aims to discuss the clinical and biological evidence supporting the existence of...
6.
Di Giorgio A, Matarazzo L, Sonzogni A, Nicastro E, Pietrobattista A, Cananzi M, et al.
Liver Int
. 2023 May;
43(7):1523-1536.
PMID: 37157951
Background And Aims: In paediatrics, porto-sinusoidal vascular disease (PSVD) is relatively unknown and probably underdiagnosed. We aimed to describe clinical phenotypes, histology and outcome of children diagnosed with PSVD. Methods:...
7.
Pinelli D, Cescon M, Ravaioli M, Neri F, Amaduzzi A, Serenari M, et al.
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048541
Surgical strategies for graft portal vein flow restoration vary from termino-terminal portal vein anastomosis to more complex bypass reconstructions. Although the surgical strategy strongly influences the post-operative outcome, the Yerdel...
8.
Rossini A, Cassibba S, Perticone F, Benatti S, Venturelli S, Carioli G, et al.
Front Endocrinol (Lausanne)
. 2023 Mar;
14:1126683.
PMID: 36967795
Introduction: Thyroid dysfunctions associated with SARS-CoV-2 acute infection have been extensively described since the beginning of COVID-19 pandemics. Conversely, few data are available on the occurrence of thyroid autoimmunity after...
9.
Novelli L, Raimondi F, Carioli G, Carobbio A, Pappacena S, Biza R, et al.
Respir Med Res
. 2022 Dec;
83:100976.
PMID: 36473331
Background: In patients with pneumonia or acute respiratory distress syndrome who survived hospitalization, one-year mortality can affect up to one third of discharged patients. Therefore, significant long-term mortality after COVID-19...
10.
Barbui T, Ghirardi A, Carobbio A, Masciulli A, Carioli G, Rambaldi A, et al.
Blood Cancer J
. 2022 Nov;
12(11):156.
PMID: 36385103
No abstract available.